{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T02:32:46Z","timestamp":1786242766847,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T00:00:00Z","timestamp":1640390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.apsb.2021.12.016","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T02:32:24Z","timestamp":1640831544000},"page":"2443-2461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Nazi","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiteng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmei","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuohan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suijia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runfeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongdao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianxing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2021.12.016_bib1","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.14841.1","article-title":"Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts","volume":"7","author":"Weiskirchen","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.apsb.2021.12.016_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu Rev Phytopathol"},{"key":"10.1016\/j.apsb.2021.12.016_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41467-017-00204-4","article-title":"The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGF\u03b2 and Notch pathways","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.12.016_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2021.12.016_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jhep.2015.04.011","article-title":"The Hippo pathway effector YAP controls mouse hepatic stellate cell activation","volume":"63","author":"Mannaerts","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.12.016_bib6","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.1074\/jbc.M111490200","article-title":"Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis","volume":"277","author":"Murphy","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2021.12.016_bib7","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.12.016_bib8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/j.gastro.2012.06.036","article-title":"Deactivation of hepatic stellate cells during liver fibrosis resolution in mice","volume":"143","author":"Troeger","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.12.016_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc4346","article-title":"Proliferation tracing reveals regional hepatocyte generation in liver homeostasis and repair","volume":"371","author":"He","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.apsb.2021.12.016_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1021\/acs.molpharmaceut.8b01030","article-title":"Rapeseed protein-derived antioxidant peptide RAP ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice","volume":"16","author":"Zhao","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2021.12.016_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2613.2009.00656.x","article-title":"Experimental mouse models for hepatocellular carcinoma research","volume":"90","author":"Heindryckx","year":"2009","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.apsb.2021.12.016_bib12","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","article-title":"Experimental models of liver fibrosis","volume":"90","author":"Yanguas","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.apsb.2021.12.016_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbt.21834","article-title":"Dose-dependent effects of alpha-naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis","volume":"31","author":"Joshi","year":"2017","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.apsb.2021.12.016_bib14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1042\/CS20150117","article-title":"Schistosome-induced cholangiocyte proliferation and osteopontin secretion correlate with fibrosis and portal hypertension in human and murine schistosomiasis mansoni","volume":"129","author":"Pereira","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.apsb.2021.12.016_bib15","doi-asserted-by":"crossref","first-page":"13817","DOI":"10.1038\/ncomms13817","article-title":"Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt","volume":"22","author":"Han","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.12.016_bib16","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1038\/s41467-020-19668-y","article-title":"AdipoR1\/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis","volume":"11","author":"Xu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.12.016_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.cdd.4401979","article-title":"Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis","volume":"14","author":"Mann","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.apsb.2021.12.016_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2021.12.016_bib19","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2337\/db09-0278","article-title":"Glucagon-like peptide 1\/glucagon receptor dual agonism reverses obesity in mice","volume":"58","author":"Pocai","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2021.12.016_bib20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/dom.13939","article-title":"Dual glucagon-like peptide-1 receptor\/glucagon receptor agonist SAR425899 improves beta-cell function in type 2 diabetes","volume":"22","author":"Visentin","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.apsb.2021.12.016_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s42255-020-0209-6","article-title":"Resolution of NASH and hepatic fibrosis by the GLP-1R\/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis","volume":"2","author":"Boland","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2021.12.016_bib22","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/hep.28962","article-title":"A novel glucagon-like peptide 1\/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice","volume":"65","author":"Valdecantos","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.12.016_bib23","first-page":"195","article-title":"A novel glucagon-like peptide 1\/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice","volume":"23","author":"aldecantos","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.12.016_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1871525716666180118152158","article-title":"Coagonist of GLP-1 and glucagon receptor ameliorates development of non-alcoholic fatty liver disease","volume":"16","author":"Patel","year":"2018","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1016\/j.apsb.2021.12.016_bib25","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0140-6736(18)30726-8","article-title":"MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study","volume":"391","author":"Ambery","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2021.12.016_bib26","doi-asserted-by":"crossref","first-page":"11880","DOI":"10.1016\/S0021-9258(18)67324-7","article-title":"Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing","volume":"261","author":"Mojsov","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2021.12.016_bib27","doi-asserted-by":"crossref","first-page":"13475","DOI":"10.1016\/S0021-9258(18)68261-4","article-title":"Glucagon gene expression in vertebrate brain","volume":"263","author":"Drucker","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2021.12.016_bib28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nchembio.209","article-title":"A new glucagon and GLP-1 co-agonist eliminates obesity in rodents","volume":"5","author":"Day","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.apsb.2021.12.016_bib29","doi-asserted-by":"crossref","first-page":"11340","DOI":"10.1074\/jbc.M708740200","article-title":"Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain","volume":"283","author":"Runge","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2021.12.016_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/bcpt.13169","article-title":"Exendin-4 from heloderma suspectum venom: from discovery to its latest application as type II diabetes combatant","volume":"124","author":"Yap","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2021.12.016_bib31","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1021\/jacs.8b01087","article-title":"Genetically encoding fluorosulfate-l-tyrosine to react with lysine, histidine, and tyrosine via SuFEx in proteins in\u00a0vivo","volume":"140","author":"Wang","year":"2018","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2021.12.016_bib32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molcel.2020.09.020","article-title":"Differential GLP-1R binding and activation by peptide and non-peptide agonists","volume":"80","author":"Zhang","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2021.12.016_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2020.05.028","article-title":"Developing covalent protein drugs via proximity-enabled reactive therapeutics","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2021.12.016_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.surg.2010.07.046","article-title":"Partial bile duct ligation in mice: a novel model of acute cholestasis","volume":"149","author":"Heinrich","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.apsb.2021.12.016_bib35","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.3389\/fimmu.2018.02781","article-title":"Host regulators of liver fibrosis during human schistosomiasis","volume":"28","author":"Kamdem","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2021.12.016_bib36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fimmu.2020.00061","article-title":"T lymphocyte-mediated liver immunopathology of schistosomiasis","volume":"11","author":"Zheng","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2021.12.016_bib37","doi-asserted-by":"crossref","first-page":"e1008947","DOI":"10.1371\/journal.ppat.1008947","article-title":"Endothelin receptors promote schistosomiasis-induced hepatic fibrosis via splenic B cells","volume":"16","author":"Kong","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2021.12.016_bib38","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-\u03b2 signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2021.12.016_bib39","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1111\/bph.14831","article-title":"Praziquantel ameliorates CCl4-induced liver fibrosis in mice by inhibiting TGF-\u03b2\/Smad signalling via up-regulating Smad7 in hepatic stellate cells","volume":"176","author":"Liu","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2021.12.016_bib40","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/bloodadvances.2017010868","article-title":"Platelet TGF-\u03b21 deficiency decreases liver fibrosis in a mouse model of liver injury","volume":"2","author":"Ghafoory","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.apsb.2021.12.016_bib41","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.12.016_bib42","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0168-8278(99)80351-1","article-title":"Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells","volume":"31","author":"Zhang","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.12.016_bib43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2012.06.004","article-title":"A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches","volume":"143","author":"Seki","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.12.016_bib44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: direct antifibrotic agents and targeted therapies","volume":"68\u201369","author":"Schuppan","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.apsb.2021.12.016_bib45","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1080\/15548627.2019.1591672","article-title":"Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation","volume":"15","author":"Baechler","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.12.016_bib46","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2021.12.016_bib47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/cen.12369","article-title":"Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease","volume":"81","author":"Kahal","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.apsb.2021.12.016_bib48","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41598-017-02866-y","article-title":"Liraglutide improves liver microvascular dysfunction in cirrhosis: evidence from translational studies","volume":"7","author":"de Mesquita","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.12.016_bib49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2021.12.016_bib50","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521004883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521004883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:53:02Z","timestamp":1761929582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521004883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2211383521004883"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2021.12.016","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2021.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}